Lab- Diagnostics

Institute of Virology, Technische Universität München / Helmholtz Zentrum München:  Research at the Institute of Virology is geared toward pathogenic human viruses such as hepatitis viruses, HIV, poxviruses or SARS virus.  Their study focuses on molecular details of the viral replication cycle, host-pathogen interactions and the role of immunity in viral diseases. The institute is equipped with state-of-the-art instrumentation, BSL2 and BSL3 laboratories and an immune monitoring unit.  In spring 2013, the Global Virus Network met in Munich to discuss the topics of control of chronic and emerging viral infections. The workshop highlighted the Durability of Vaccine-induced Immune Response, and was led by GVN Co-Founder and International Scientific Advisor, Dr. Robert Gallo and Ulrike Protzer, among other speakers at the event.

The Microbiology, Immunology and Pathology (MIP) Department is comprised of over 400 individuals who share a common passion for solving some of the most important human and animal health problems today. Research programs include those related to mycobacteria, retroviruses, prions, and arthropod-borne infectious diseases, as well as the diagnostic investigation of naturally-occurring animal diseases. A leader in education, MIP provides the only microbiology undergraduate degree program in Colorado, a graduate program that provides training in a number of cutting-edge disciplines, and several specialized veterinary residency training programs.

Karolinska Institute (KI) is one of the world’s leading medical universities. Their mission is centered toward research and education, to help improve people’s health. In Sweden, Karolinska Institute accounts for over 40 per cent of the medical academic research and has the largest collection of medical education. Since 1901 the Nobel Assembly at Karolinska Institute has selected the Nobel laureates in Physiology or Medicine, and several alumni have won the prestigious award.

Finding solutions to prevent, treat and cure infectious diseases and understanding the complexities of microbes and the immune system requires innovative approaches and concentrated effort. This is why the University of Melbourne – a world leader in education, teaching and research excellence – and The Royal Melbourne Hospital – an internationally renowned institution providing outstanding care, research and learning –partnered to create the Peter Doherty Institute for Infection and Immunity (Doherty Institute); a centre of excellence where leading scientists and clinicians collaborate to improve human health globally.

The Pirbright Institute is a world leading centre of excellence in research and surveillance of virus diseases of farm animals and viruses that spread from animals to humans. We receive strategic funding from the Biotechnology and Biological Sciences Research Council (BBSRC), and work to enhance capability to contain, control and eliminate these economically and medically important diseases through highly innovative fundamental and applied bioscience. The Institute employs around 450 staff plus research students and visiting scientists. and has recently moved to one campus in Pirbright, Surrey, where investment by BBSRC has resulted in a redevelopment of the site and the construction of a high level biosecurity facility – the BBSRC National Virology Centre: The Plowright Building and a containment level two facility, The Jenner Building.
The Pirbright Institute provides the UK with capacity to predict, detect, understand and respond to the threat and potential attack of serious viral diseases of livestock and viruses that spread from animals to humans. These viral diseases may not be present in the UK (endemic) and only circulating abroad (exotic).The Institute’s science strategy is delivered through three strategic programmes: Avian Viral Diseases; Livestock Viral diseases and Vector-borne Viral Diseases.

The University of Wisconsin-Madison (UW-Madison) is world renowned for its research and translational programs in virology and the global reach of these programs.  The UW-Madison Global Health Institute lies at the crossroads of these endeavors and serves as an umbrella organization for broad-based activities on emerging themes in global health.  Virologists at UW-Madison study agents infecting humans, animals, and plants, including highly pathogenic viruses (e.g. the ebolaviruses) and viruses with pandemic potential (e.g. influenza virus, arboviruses).  Activities range from basic research to the development of vaccines and therapeutics to public health and policy.  UW-Madison has particular strengths in emerging viral pathogens and zoonosis, including rapid detection and characterization of viral agents, the development of animal models (especially primates), and the development of countermeasures such as vaccines and therapeutics.

The University of Texas Medical Branch (UTMB) is known worldwide for its academic excellence in virology research. The scientists and academic staff at the university include some of the world’s foremost infectious disease experts, and research at the university results in groundbreaking biomedical discoveries and the development of vaccines, therapeutics and diagnostic tools. The Galveston National Laboratory (GNL), the flagship high containment facility of the UTMB Institute of Human Infections and Immunity, resides on the UTMB campus and houses research on Ebola, chikungunya, MERS coronavirus, dengue, West Nile, and other emerging viruses. The Institute also includes the Center for Biodefense & Emerging Infectious Diseases, the Sealy Center for Vaccine Development, the Center for Tropical Diseases, and the McLaughlin Endowment for Infection and Immunity.